News & Analysis as of

Startups Acquisitions Due Diligence

DarrowEverett LLP

Your Business's Growth Blueprint: Why Solid Legal Documents Matter

DarrowEverett LLP on

Every successful business owner has ambition to grow, scale, and take his/her company to the next level. However, there’s one critical, often overlooked aspect that can make or break a business’s ability to get to that level:...more

Pillsbury - Propel

The IP Landmine That Can Kill Your Startup’s Exit: Avoiding Common Ownership Pitfalls

Pillsbury - Propel on

Unclear intellectual property (IP) ownership can pose significant challenges for startups, especially during a sale process (i.e., M&A) or investment rounds. Investors and buyers meticulously examine the chain of title for IP...more

Hutchison PLLC

Inside a $175M Deal: Tim McLoughlin & Joshua Hayes Live From RDU Startup Week

Hutchison PLLC on

What really happens behind the scenes of a $175 million startup deal? In a special live episode of the Founder Shares podcast, recorded at Raleigh-Durham Startup Week, Tim McLoughlin, managing partner of CoFounders Capital,...more

IR Global

Defence Tech – Valuation & Financial Advisory Services For Success

IR Global on

The defense technology sector (“defense tech”) has experienced remarkable growth in recent years, with projections indicating continued expansion in the near future. This surge is largely driven by increased global defense...more

Foley & Lardner LLP

The Dealmaking Slowdown: A Time for Startups to Prepare

Foley & Lardner LLP on

As the slowdown in dealmaking continues, both buyers and sellers are left to consider their options moving forward during this period of extreme uncertainty and market volatility. To put the current slowdown in perspective,...more

Orrick, Herrington & Sutcliffe LLP

OLNS#13 – M&A in German Tech: A Playbook for Buyers and Sellers - English

About the Orrick Legal Ninja Series – OLNS In substantially all of the major world markets, we have dedicated technology lawyers who support young German technology companies on their growth trajectory through all stages. As...more

Fenwick & West LLP

What Startups and Big Pharma Need to Know About AI Drug Discovery

Fenwick & West LLP on

Integrating AI tools into drug discovery introduces a mix of opportunities and challenges for startups and large pharmaceutical companies. These challenges often center on intellectual property (IP) risks, licensing...more

Foley & Lardner LLP

The Opportunities, Risks, And Rewards Of AI Acquisitions

Foley & Lardner LLP on

Amid a period of recalibration, the artificial intelligence industry is experiencing a transformational phase. According to a recent report from Stanford’s Institute for Human-Centered Artificial Intelligence that closely...more

Foley & Lardner LLP

Positioning for the Exit at the Entrance

Foley & Lardner LLP on

Startup founders are constantly seeking ways to gain a competitive edge and secure their place in the market, including positioning their company as an attractive acquisition target from the very beginning. While building a...more

Foley & Lardner LLP

Retraining the Acquisition Model: How to Approach the Risks and Rewards of Deals With Artificial Intelligence Targets

Foley & Lardner LLP on

In recent years, companies specializing in artificial intelligence (AI) technologies have been increasingly coveted acquisition targets. With the AI field transforming our approaches to key issues – from climate change to...more

McDermott Will & Emery

[Ongoing Program] Life Sciences Dealmaking Symposium 2020 - November 17th, 8:00 am - 2:00 pm EST

McDermott Will & Emery on

In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to...more

McDermott Will & Emery

[Ongoing Program] Life Sciences Dealmaking Symposium 2020 - Part 3 - November 10th, 12:00 pm - 1:00 pm EST

McDermott Will & Emery on

In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to...more

McDermott Will & Emery

[Ongoing Program] Life Sciences Dealmaking Symposium 2020 - Part 2 - October 27th, 12:00 pm - 1:00 pm EDT

McDermott Will & Emery on

In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to...more

McDermott Will & Emery

[Ongoing Program] Life Sciences Dealmaking Symposium 2020 - Part 1 - October 20th, 12:00 pm - 1:00 pm EDT

McDermott Will & Emery on

In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to...more

Latham & Watkins LLP

Key Considerations for Middle East Entities Looking to Invest in US Technology Companies

Latham & Watkins LLP on

Four of Latham & Watkins’ leading emerging company partners in Silicon Valley, Luke Bergstrom, Tad Freese, Jim Morrone and JD Marple, recently hosted a webinar titled “Achieving Successful Outcomes as a Non-US Company...more

JD Supra Perspectives

Heads Up on Startups: What Acquirers Need to Know Prior to the Purchase

JD Supra Perspectives on

Acquiring a startup often provides the acquirer with access to new markets, products, solutions and services, as well as innovative ideas and a pipeline of future products. While the idea of acquiring the “next big thing” is...more

16 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide